EG-70

· enGene, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EG-70, covering 2026-01-26 to 2026-01-26. Get the full timeline:

Most recent: Clinical Trial Update: LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve [Phase 1, Phase 2]

See pricing